Here are four points:
1. Zacks presently has a $5.25 price target on EndoChoice stock.
2. EndoChoice has a 50-day moving average price of $4.78 and a 200-day moving average price of $8.50.
3. The company has a 12-month low of $3.70 and a 12-month high of $19.69.
4. The company’s market cap is $124.72 million.
More articles on GI/endoscopy:
4 GI physicians in the news — March 25, 2016
Dr. Gregory Scheible 1st in Indiana to implant Orbera intragastric balloon: 4 points
Emails show Olympus hiked up duodenoscope price 28% after CRE outbreak at UCLA: 8 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.